GrantExec, a Euna Solutions® company

Grants for Public housing authorities - Health

Explore 2,127 grant opportunities

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Aug 16, 2023

This funding opportunity supports students enrolled in dual-degree medical and research training programs, helping them develop into independent physician-scientists through mentored research and clinical training.

Education
State governments
Youth Mental Health & Wellbeing Challenge Grant
$2,500,000
Colorado Department of Law
State

Application Deadline

Jan 15, 2025

Date Added

Dec 2, 2024

This funding opportunity supports Colorado schools and community organizations in developing collaborative projects to improve youth mental health and reduce vaping among children and teens.

Health
Public and State controlled institutions of higher education
Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21)
$4,000,000
U.S. Department of Health and Human Services (Centers for Disease Control and Prevention - ERA)
Federal

Application Deadline

Oct 29, 2024

Date Added

Feb 25, 2024

This grant provides funding for research projects focused on improving health outcomes through lifestyle medicine for individuals affected by the 9/11 attacks, including responders and survivors receiving care under the WTC Health Program.

Health
State governments
Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
$1,500,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 28, 2024

Date Added

Aug 20, 2021

The "Blueprint Medtech: Small Business Translator" grant aims to support small businesses in developing and testing therapeutic and diagnostic devices for nervous or neuromuscular disorders, with funding and expert assistance provided for activities such as clinical studies, safety testing, and design validation, ultimately leading to FDA or IRB approval.

Health
State governments
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed)
$250,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 17, 2024

Date Added

Aug 24, 2022

The REDI: NIA Entrepreneurship Enhancement Award (R25) is a grant aimed at providing entrepreneurial training to graduate students, postdocs, and early career scientists in fields related to aging and Alzheimer's disease research, to prepare them for diverse career paths.

Health
State governments
NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F31 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 3, 2025

Date Added

Jan 21, 2025

This funding opportunity supports promising predoctoral students from diverse backgrounds to conduct research in translational studies related to Alzheimer's disease and related dementias, fostering skills essential for advancing this critical field.

Health
State governments
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowed)
$3,000,000
U.S. Department of Health and Human Services - National Institutes of Health
Federal

Application Deadline

Jul 30, 2024

Date Added

Mar 28, 2024

Notice of Funding Opportunity Description Background Although vaccines are among the most effective approaches to control viral diseases, developing a prophylactic or therapeutic HIV vaccine has proven elusive. There are no licensed vaccines for HIV. Strategies for induction of HIV broadly neutralizing antibodies will likely require repeated exposures over long periods, including immunization with distinct antigens in sequential order. Such immunization strategies will require development of technologies for controlled vaccine release. Recent advances in materials-based science, controlled release technologies, delivery systems, and immunology provide opportunities to enhance the quality, potency and durability of vaccine-induced T cell and antibody responses to HIV-1. Materials-based approaches can be engineered to improve the stability, spatiotemporal release, and presentation of multiple vaccine components; for example, by controlling the time frame and dose of vaccine delivery over days to weeks. Recent studies have shown that a slow-release vaccine is superior to bolus administration at inducing breadth, potency, and durability of antibody responses to HIV antigens by prolonging antigen exposure in the germinal centers, thereby enhancing the maturation of B cells and generating stronger humoral immune responses. Further research is needed to elucidate the mechanisms underlying the immunological improvements observed with slow-release vaccine delivery and to translate such concepts into clinical application. It will be crucial to determine how the duration of exposure to vaccine components impacts immune cell biology, and how to calibrate vaccine release to improve responses while avoiding immune exhaustion and over-activation. Advancing safe, effective, and well-tolerated controlled release vaccines is an unmet need that may enhance vaccine effectiveness and practicality, leading to better adherence to complex regimens, fewer adverse reactions, and cost savings. Finally, iterative behavioral studies during product development to determine vaccine/provider product expectation/preferences are critical to facilitate product uptake and use.

Health
State governments
Notice of Intent to Publish a Funding Opportunity for Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein NRSA Individual Postdoctoral Fellowship (F32)
$75,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 17, 2025

Date Added

Nov 26, 2024

This funding opportunity supports postdoctoral researchers conducting studies on the impact of early environmental factors on child health using a large national dataset.

Health
State governments
Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)
$350,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 2, 2024

Date Added

Aug 16, 2024

This funding opportunity supports primary care centers in implementing genomic screening for common genetic conditions to improve disease prevention and care, particularly in underrepresented communities.

Health
State governments
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
$150,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 8, 2025

Date Added

May 10, 2023

This funding opportunity supports research initiatives focused on non-communicable diseases related to HIV at institutions in low- and middle-income countries, encouraging innovative projects and collaborations to improve health outcomes for people living with HIV.

Education
State governments
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 9, 2025

Date Added

Nov 21, 2024

This funding opportunity provides financial support for research projects that address the information and practice needs of caregivers and professionals working with children who experience delays in language development, particularly focusing on diverse communities.

Health
State governments
Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed)
$2,800,000
U.S. Department of Health and Human Services - National Institutes of Health
Federal

Application Deadline

Jul 30, 2024

Date Added

Mar 1, 2024

This Notice of Funding Opportunity (NOFO) seeks to foster new multi-disciplinary teams to address how HIV Comorbidities and co-infections within the missions of NIDDK and NIAID interact with viral reservoirs, potentially confounding cure strategies aimed at either sustained viral suppression or elimination from the body. These teams will mechanistically interrogate the impact of inflammation, metabolic perturbations, or other pathophysiological processes associated with these comorbidities or co-infections on reservoir dynamics, and/or the interplay of these conditions and co-infections on HIV reservoir biology in ways that are likely to interact with potential cure strategies.

Food and Nutrition
State governments
Notice of Intent to Publish a Funding Opportunity Announcement for Intellectual and Developmental Disabilities Research Centers 2025 (P50 Clinical Trial Optional)
$18,000,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 15, 2025

Date Added

May 13, 2025

This funding opportunity is designed to support research centers that focus on improving the diagnosis, treatment, and prevention of intellectual and developmental disabilities through collaborative and interdisciplinary research efforts.

Health
State governments
Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 2, 2025

Date Added

Apr 25, 2024

This funding opportunity provides rapid financial support for researchers to study health outcomes related to urgent events like pandemics, natural disasters, or sudden policy changes, allowing them to gather critical data quickly.

Education
State governments
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 26, 2025

Date Added

Dec 21, 2023

This grant provides funding for early stage investigators to pursue innovative and high-risk research projects involving human participants, without the need for preliminary data.

Education
State governments
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 8, 2025

Date Added

Jun 29, 2023

This funding opportunity supports innovative research aimed at understanding and improving treatment for schizophrenia and related disorders in individuals aged 35 and older.

Health
State governments
Ida Housing Recovery and Reimbursement Program - Program Administration Services
$400,000
New York State Homes and Community Renewal, Office of Resilient Homes and Communities (RHC)
State

Application Deadline

Not specified

Date Added

Jun 15, 2024

This program provides financial assistance to non-profit housing developers to help homeowners in select New York counties recover from storm damage through reimbursements and repairs.

Housing
Nonprofits
National Alzheimers Coordinating Center (U24 Clinical Trial Not Allowed)
$10,350,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 17, 2025

Date Added

May 13, 2025

This funding opportunity supports U.S. institutions in establishing a national center to coordinate and enhance research on Alzheimer's Disease and related dementias through data collection, integration, and collaboration efforts.

Health
Public and State controlled institutions of higher education
Cellular Senescence Network (SenNet): SenNet Data Coordination, Integration and Organizational Center (U24 or UM1)
$3,400,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 13, 2025

Date Added

May 29, 2025

This funding opportunity supports the establishment of a center to coordinate research on cellular senescence, aiming to improve health outcomes by identifying tissue-specific markers and developing new therapeutic strategies, targeting a wide range of eligible applicants including educational institutions, nonprofits, and businesses.

Health
State governments
Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
$200,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 7, 2024

Date Added

Jan 11, 2021

The purpose of this funding opportunity announcement is to provide tailored support for early stage investigators (ESIs) to initiate basic or translational research with nonhuman primates (NHPs). These awards will allow ESIs additional funds, time to generate preliminary data, and the opportunity to establish all skills needed to set up and run an NHP laboratory independently. It is expected that these awards will thereby improve an ESIs ability to secure larger research awards (e.g., R01) and will facilitate their transition to independent tenure-track positions.

Health
State governments